Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive therapy in movement disorders: an update.

Richard Kennedy1, Dinesh Mittal, Judith O'Jile

  • 1Department of Psychiatry, University of Missippi Medical Center, Jackson, USA. richard-kennedy@att.net

The Journal of Neuropsychiatry and Clinical Neurosciences
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: Concerns regarding the WHO guideline on infertility: implications for contemporary reproductive medicine.

Human reproduction (Oxford, England)·2026
Same author

Preclinical efficacy of dendritic cells loaded with newly identified HPV11 E6-derived CD8<sup>+</sup> T cell epitopes.

NPJ vaccines·2026
Same author

Lower Urinary Tract Symptoms and Cognitive Impairment Among Participants in the REGARDS Cohort Study.

Journal of the American Geriatrics Society·2026
Same author

Outcomes of iliofemoral venous stenting in women with venous ulcers.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Lexical and clinical predictors of verbal fluency interword intervals preceding cognitive impairment.

Neuropsychologia·2026
Same author

Recommendations from the WHO guideline for the prevention, diagnosis, and treatment of infertility.

Fertility and sterility·2025

Electroconvulsive therapy (ECT) can improve motor symptoms in Parkinson's disease and other movement disorders, even without co-occurring mood conditions. This review summarizes recent findings on ECT's benefits for neurological patients.

Area of Science:

  • Neurology
  • Psychiatry
  • Neuroscience

Background:

  • Electroconvulsive therapy (ECT) is established for psychiatric conditions, notably depression.
  • Increasingly, ECT is utilized in patients with neurological disorders.
  • Prior research suggests ECT may benefit movement disorders like Parkinson's disease, irrespective of psychiatric comorbidities.

Purpose of the Study:

  • To review recent literature (1990-2000) on the efficacy of ECT for movement disorders.
  • To evaluate ECT's impact on motor symptoms in Parkinson's disease and related conditions.
  • To explore the neurobiological underpinnings and limitations of ECT in movement disorder treatment.

Main Methods:

  • Systematic review of studies published between 1990 and 2000.
  • Analysis of clinical evidence regarding ECT's effects on motor symptoms.

Related Experiment Videos

  • Examination of case reports for various movement disorders.

    • Main Results:

    • Substantial evidence confirms ECT improves motor symptoms in Parkinson's disease patients, with or without mood disorders.
    • Limited case reports suggest potential benefits of ECT for other movement disorders.
    • ECT influences neurotransmitter systems implicated in these neurological conditions.

    Conclusions:

    • ECT demonstrates significant potential for alleviating motor symptoms in Parkinson's disease.
    • Further research is warranted to confirm ECT's efficacy in a broader range of movement disorders.
    • Understanding ECT's neurochemical effects is crucial for optimizing its use in neurological treatments.